Skip to main content
. 2012 Dec 13;34(2):171–208. doi: 10.1210/er.2012-1008

Table 3.

Average bioavailabilities and half-lives of progestogens

Progestogen Dose (mg) Bioavailability (%) Half-life (h) Ref.
Progesterone 100, 200, 300 <5 16.2–18.3 16
MPA 10 >90 24 17
Megestrol acetate 160 NA 22.3 18
Cyproterone acetate 2 NA 54.0–78.6 19
Chlormadinone acetate 2 ∼100 80.1 20
Medrogestone 5 NA 34.9 21
Dydrogesterone 10 28 14–17 a
Nomegestrol acetate 2.5 60 50 22
Trimegestone 0.5 ∼100 15 a
Norethindrone 1 64 8 23
Levonorgestrel 0.15–0.25 89/99b 9.9/13.2b 24
Desogestrel 0.15 62/76b 11.9/23.8b 25, 26
Gestodene 0.075 87/99b 12–14 27, 28
Dienogest 4 96.2 10.8/11.6b 29
Drospirenone 3 66 31.1–32.5 30, 31

NA, No data available.

a

The data were obtained from a package insert.

b

Multiple bioavailability or half-life values are shown.